Organic Chemistry TRIZ Cases

A methacrylate composition reacts thiol and acryloyloxy groups to form cured products with enhanced mechanical properties.

A TADF host molecule transfers energy to a chiral dopant for circularly polarized light emission.

Conjugating BTK inhibitors with E3 ligase ligands degrades the target protein, overcoming resistance and boosting potency.

Heterobifunctional compounds recruit E3 ligases to degrade oncogenic proteins, bypassing resistance mechanisms inherent to conventional DNA-damaging therapies.

Formula I pyrimidine compounds inhibit CaMK1D kinases by placing specific substituents on the core to minimize off-target SYK inhibition.

A novel organic compound structure reduces driving voltage in light emitting devices.

Irradiating cut sugarcane with UVB or UVC light triggers stilbene synthesis, overcoming the natural lack of resveratrol and piceatannol in raw crops.

Steric shielding at the thiophene 2-position prevents oxidative doping, allowing stable ambient operation without complex encapsulation.

Multi-targeted liphagal analogs inhibit CDK7, CDK4, and PIM2 kinases to overcome single-agent resistance in cancer therapy.

Nitrooxy cycloalkane derivatives address inadequate water retention management by enabling controlled delivery of antihypertensive agents.

Polycyclic aryl triazole compounds enable high luminance and thermal stability in blue-emitting electroluminescent devices.

A 1-Benzyl-4-Phenyl-1H-1,2,3-triazole coating forms a protective passive film on steel rebars.

Novel condensed heterocyclic compounds inhibit BCL-2 proteins with improved pharmaceutical solubility, reducing dose-limiting toxicity in cancer treatment.

Compounds bind the Max leucine zipper to disrupt heterodimerization, resolving selectivity issues and reducing side effects in cancer therapy.

A pi-conjugated compound with diarylamino groups achieves thermally activated delayed fluorescence for organic electroluminescent elements.

Synthesized nanopores with non-collapsible cavities resolve resolution and structural regularity trade-offs to enable accurate nucleic acid sequencing.

Combining two distinct leveling agents improves surface smoothness and reduces defects in high aspect ratio features.

Decarboxylated folate derivatives with aliphatic chains form covalent bonds with proteins to enhance analytic sensitivity in non-radioisotopic assays.

Substituted quinazoline compounds form covalent bonds with KRAS G12C mutant proteins to inhibit their activity.

Macrocyclic compounds overcome resistance to standard tyrosine kinase inhibitors by targeting mutant EGFR forms with enhanced binding affinity.

Selective dopamine D4 receptor antagonists reduce cocaine self-administration while preserving cognitive function.

Formula I compounds inhibit KMO enzyme activity to reduce neurotoxic metabolite production.

Modified succinimide additive improves soot dispersancy, preventing filter plugging and oil thickening in engines.

Structurally modified carnosine analogues resist carnosinase degradation, enabling effective metabolic disorder treatment without toxicity from high doses.

Doping thiol-yne stereoelastomers with spiropyran mechanophores enables strain rate-dependent mechanochromism.

Polymer slippery liquid-infused porous surfaces release antimicrobial agents to kill planktonic microorganisms and prevent biofilm formation.

A photo-decomposable quencher suppresses acid diffusion in resist compositions, maintaining resolution and sensitivity during KrF and ArF lithography.

Fluidized bed reactor synthesizes melamine at low pressure, eliminating complex solid-liquid separation stages by producing dry powder directly.

A phenol recovery process separates distillation and cracking heat duties using distinct temperature utilities.

Measures 5-HETE and 5-oxoETE metabolites in urine to diagnose chronic intermittent hypoxia without invasive blood sampling.

Azole bicyclic heteroaryl compounds inhibit mutant EZH2 to reduce aberrant H3-K27 methylation in cancers.

Quinolin-2-yl nitrones resolve the contradiction between treatment efficacy and side effects by inhibiting BChE and MAO-B enzymes.

Bifunctional copper catalysts replace toxic chromite systems, eliminating metal ion leaching while maintaining high selectivity and scalability.

Heteroaryl-substituted amine derivative maintains low driving voltage at increased layer thickness.

A resist composition with a novel acid generator enhances lithography properties and pattern formation.

A hydrothermal method using a protective agent to synthesize phase-pure M1 MoVTeNb oxide catalysts with high specific surface area.

Novel condensed cyclic compounds optimize charge recombination in organic light-emitting devices.

A benzene compound with one cyano group and specific substituents emits delayed fluorescent light for organic light-emitting devices.

A brominating agent reacts with a pyrazole compound to produce an anthranilamide intermediate.

Dimerization of pyridine compounds using a metal catalyst supported on silica and alumina.

A palladium complex catalyst converts 2-trifluoromethyl pyridine derivatives with carbon monoxide to produce isonicotinic acid esters.

A heterocyclic compound stabilizes electrons through HOMO delocalization to enhance organic light emitting device performance.

Branched quaternary ammonium compounds suppress electrolyte decomposition under high voltage, maintaining lithium ion conductivity.